Penumbra, Inc. (PEN)
323.79
-1.39
(-0.43%)
USD |
NYSE |
Aug 24, 16:00
323.79
0.00 (0.00%)
After-Hours: 20:00
Penumbra Price to Book Value : 8.332 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 8.368 |
| August 20, 2026 | 8.331 |
| August 19, 2026 | 8.410 |
| August 18, 2026 | 8.356 |
| August 17, 2026 | 8.419 |
| August 14, 2026 | 8.415 |
| August 13, 2026 | 8.408 |
| August 12, 2026 | 8.404 |
| August 11, 2026 | 8.396 |
| August 10, 2026 | 8.388 |
| August 07, 2026 | 8.354 |
| August 06, 2026 | 8.359 |
| August 05, 2026 | 8.317 |
| August 04, 2026 | 8.343 |
| August 03, 2026 | 8.312 |
| July 31, 2026 | 8.265 |
| July 30, 2026 | 8.230 |
| July 29, 2026 | 8.238 |
| July 28, 2026 | 8.234 |
| July 27, 2026 | 8.221 |
| July 24, 2026 | 8.202 |
| July 23, 2026 | 8.180 |
| July 22, 2026 | 8.144 |
| July 21, 2026 | 8.167 |
| July 20, 2026 | 8.183 |
| Date | Value |
|---|---|
| July 17, 2026 | 8.191 |
| July 16, 2026 | 8.224 |
| July 15, 2026 | 8.15 |
| July 14, 2026 | 8.138 |
| July 13, 2026 | 8.207 |
| July 10, 2026 | 8.185 |
| July 09, 2026 | 8.181 |
| July 08, 2026 | 8.164 |
| July 07, 2026 | 8.191 |
| July 06, 2026 | 8.189 |
| July 02, 2026 | 8.197 |
| July 01, 2026 | 8.142 |
| June 30, 2026 | 8.125 |
| June 29, 2026 | 8.417 |
| June 26, 2026 | 8.448 |
| June 25, 2026 | 8.469 |
| June 24, 2026 | 8.441 |
| June 23, 2026 | 8.475 |
| June 22, 2026 | 8.437 |
| June 18, 2026 | 8.464 |
| June 17, 2026 | 8.436 |
| June 16, 2026 | 8.497 |
| June 15, 2026 | 8.491 |
| June 12, 2026 | 8.504 |
| June 11, 2026 | 8.494 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Boston Scientific Corp. | 2.844 |
| Globus Medical, Inc. | 2.368 |
| Abbott Laboratories | 3.950 |
| AngioDynamics, Inc. | 3.852 |
| Teleflex, Inc. | 2.017 |
Price to Book Value Related Metrics
| PE Ratio | 79.51 |
| PS Ratio | 8.489 |
| PEG Ratio | 9.976 |
| Price to Free Cash Flow | 59.17 |
| Price | 323.79 |
| Earnings Yield | 1.26% |
| Market Cap | 12.75B |
| PEGY Ratio | 9.976 |
| Operating PE Ratio | 68.19 |
| Normalized PE Ratio | 79.51 |